Asthma control · adults and adolescents with asthma
1 finding from 1 review
Unscheduled healthcare utilisation ‐ number of hospital or GP/ED visits · adults and adolescents with asthma
1 finding from 1 review
Anxiety · adults and adolescents with asthma
1 finding from 1 review
Depression at endpoint · adults and adolescents with asthma
1 finding from 1 review
Adherence · adults and adolescents with asthma
1 finding from 1 review
Intervention not reported
Change in FEV1 1 h after dosing in ml · participants with an exacerbation of COPD; people with asthma excluded from our analysis
1 finding from 1 review
Intervention not reported
Serious adverse events · participants with an exacerbation of COPD; people with asthma excluded from our analysis
The intervention showed no clear difference in serious adverse events (low certainty).
1 finding from 1 review
Intervention not reported
Change in FEV1 closest to 1 h after dosing in ml · participants with an exacerbation of COPD; people with asthma excluded from our analysis
1 finding from 1 review
Intervention not reported
Change in dyspnoea score during the first 24 h after dosing · participants with an exacerbation of COPD; people with asthma excluded from our analysis
1 finding from 1 review
Intervention not reported
Adverse events/side effects · participants with an exacerbation of COPD; people with asthma excluded from our analysis
The intervention showed no clear difference in adverse events/side effects (low certainty).
1 finding from 1 review
Intervention not reported
Mortality · children with acute asthma
1 finding from 1 review
Intervention not reported
Serious adverse events · children with acute asthma
1 finding from 1 review
Intervention not reported
Asthma symptom score at the acute phase · children with acute asthma
1 finding from 1 review
Intervention not reported
Pneumonia · children with acute asthma
1 finding from 1 review
Intervention not reported
Exacerbations Number of events · adults and children with purulent bronchiectasis
The intervention probably leads to lower exacerbations Number of events (moderate certainty).
1 finding from 1 review
Intervention not reported
Hospitalisations Number of events · adults and children with purulent bronchiectasis
The intervention showed no clear difference in hospitalisations Number of events (moderate certainty).
1 finding from 1 review
Intervention not reported
Emergence of resistance Number of events · adults and children with purulent bronchiectasis
The intervention probably leads to higher emergence of resistance Number of events (moderate certainty).
1 finding from 1 review
Intervention not reported
St George Respiratory Questionnaire (SGRQ) total Mean and standard deviation. Scale from 0 to 100 · adults and children with purulent bronchiectasis
1 finding from 1 review
Dyspnoea ‐ CRQ dyspnoea Scale 1 to 7. Higher is better and 0.5 units is a clinically important difference · patients with chronic obstructive pulmonary disease
1 finding from 1 review
Change in SGRQ total score · patients with chronic obstructive pulmonary disease
1 finding from 1 review